WuXi Biologics (2269.HK), a leading global open-access biologics technology platform company, offering end-to-end solutions for biologics discovery, development and manufacturing,...
Read moreSynpromics Ltd is pleased to announce a new collaboration with UCL to generate a range of synthetic gene promoters for...
Read moreQuotient Sciences, the drug development services organization, announces it has acquired Pharmaterials, a contract development and manufacturing organization (CDMO) based...
Read moreThe U.S. Patent & Trademark Office (PTO) granted Argentum Pharmaceuticals LLC's petition for inter partes review (IPR) against all patent...
Read moreCEVEC Pharmaceuticals GmbH (CEVEC), the expert in the production of tailor-made recombinant glycoproteins and gene therapy vectors, today announced that...
Read moreTrakCel announced a partnership agreement to incorporate its needle-to-needle supply chain management platform into the CGT Catapult’s large-scale cell and...
Read moreMithra , a company specialized in Women’s Health, is pleased to announce that the Mithra CDMO1 has received Good Manufacturing Practice (GMP)...
Read moreAerie Pharmaceuticals Inc,a clinical-stage pharmaceutical company focused on the discovery, development and commercialization of first-in-class therapies for the treatment of...
Read moreSun Pharma & Moebius Medical sign exclusive global licensing deal to develop novel liposomal non-opiod pain product for osteoarthritis Sun Pharma...
Read moreTakeda Pharmaceuticals Company Limited announced that it will invest more than 100 Million Euros to build a new manufacturing plant...
Read morePharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.
© 2017 Copyright © Valuemediaservices 2017 All rights reserved.
Notifications